Top Clinical Trials companies in United Kingdom by EBIT

This ranking features the top 53 Clinical Trials companies in United Kingdom ranked by EBIT, totaling a EBIT of USD 20.52 B, for July 08, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in United Kingdom has the highest EBIT ?

The Clinical Trials company in United Kingdom with the highest EBIT is AstraZeneca PLC (LSE: AZN.L) at USD 10.37 B.

Which Clinical Trials company in United Kingdom has the lowest EBIT ?

The Clinical Trials company in United Kingdom with the lowest EBIT is Cizzle Biotechnology Holdings Plc (LSE: CIZ.L) at None.

What are the top 10 Clinical Trials companies in United Kingdom by EBIT ?

The top 10 Clinical Trials companies in United Kingdom by EBIT are AstraZeneca PLC, GSK plc, RELX Plc, Haleon plc, Hikma Pharmaceuticals PLC, ConvaTec Group Plc, LivaNova PLC, hVIVO plc, Advanced Medical Solutions Group plc and Bioventix PLC.

What are the bottom 10 Clinical Trials companies in United Kingdom by EBIT ?

The bottom 10 Clinical Trials companies in United Kingdom by EBIT are Cizzle Biotechnology Holdings Plc, Aptorum Group Limited, ImmuPharma plc, Akari Therapeutics, Plc, Roivant Sciences Ltd., Clarivate Plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, Autolus Therapeutics plc and COMPASS Pathways plc.